Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Dexcom, Inc.

Clinical trials sponsored by Dexcom, Inc., explained in plain language.

DexCom, Inc. DXCM NASDAQ

A medical device company specializing in continuous glucose monitoring systems for diabetes.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet recruiting 1 Not yet finished but already full! 3 Completed 1

World's largest Real-World CGM study aims to unlock diabetes management secrets

Knowledge-focused Not yet recruiting

This global registry study follows 5,000 people with diabetes who use a Dexcom continuous glucose monitor (CGM). Researchers will track changes in HbA1c, a key measure of blood sugar control, over time. The goal is to understand how CGM use affects diabetes management in real-wor…

Sponsor: DexCom, Inc. • Aim: Knowledge-focused

Last updated Jul 04, 2026 00:00 UTC